Smith & Nephew Stock
Smith & Nephew plc
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United Kingdom
- CEO
- Deepak S. Nath
- Employees
- 18,362
- Market cap
- £9.1 B
- IPO
- 01/07/1988
Smith & Nephew plc operates globally as a developer, manufacturer, marketer, and seller of medical technology within the healthcare sector. Founded in 1856, the company is headquartered in Watford, United Kingdom. With 18,362 employees, Smith & Nephew primarily serves healthcare providers through a diverse range of…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Smith & Nephew stock: price history
1D
-0.3%
1W
+6.3%
1M
+4.1%
6M
-14.5%
YTD
-12.4%
1Y
-19.1%
2Y
-2.2%
5Y
-15.1%
10Y
-12.5%
Next earnings date
Next earnings date
23/02/2027 (in 129 days)
Volatility around earnings
~70% stronger price swings than usual
Ask the agents about Smith & Nephew
Analyst assessment of Smith & Nephew
0
STRONG BUY
7
BUY
9
HOLD
1
SELL
0
STRONG SELL
17
TOTAL · Hold
As of: 03/10/2023
Smith & Nephew stock metrics
P/E
19.02
P/B
2.36
EV/EBITDA
9.13
RETURN ON EQUITY
5.8%
NET MARGIN
9.8%
DEBT/EQUITY
0.73
DIVIDEND YIELD
2.7%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
97.7%
FLOAT SHARES
817,803,841
AVG. DAILY VOLUME (30D)
2,807,789
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about Smith & Nephew stock
What does Smith & Nephew do?
Smith & Nephew plc is a company in the Healthcare sector, Medical - Devices industry, headquartered in United Kingdom.
The CEO is Deepak S. Nath, the company employs around 18,362 people.
The IPO was on 01/07/1988; the stock trades on LSE under the ticker SN.L.
What do analysts say about Smith & Nephew stock?
17 analysts rate the stock, the consensus is Hold (as of 03/10/2023).
This is an external assessment, not a statement by Market Jury.
When does Smith & Nephew report next?
The next earnings date is 23/02/2027.
Around past earnings, price swings were roughly 70% stronger than usual.
Does Smith & Nephew pay a dividend?
Yes. The last dividend was £11.75 per share, ex-date 01/10/2026, paid on 06/11/2026.
The dividend yield is 2.7% (as of 30/06/2026).
Which stocks are comparable to Smith & Nephew?
Comparable stocks include LivaNova, Abbott Laboratories, Medtronic, Stryker, Boston Scientific, Edwards Lifesciences, Siemens Healthineers and DexCom.
How can I get Smith & Nephew stock analyzed?
Clicking "Analyze stock" lets five strategies assess Smith & Nephew against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.